Study on the effective volume of pericapsular nerve group block in hip surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055345

Enrollment

Unknown

Registered

2022-01-07

Start date

2022-02-01

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:0.4% Ropivacaine 10ml

Group 2:0.4% Ropivacaine 20ml

Group 3:0.4% Ropivacaine 30ml

Eligibility

Sex/Gender

All

Age

60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Ineffective conservative treatment, with indications for hip surgery; 2. The American Society of Anesthesiologists is graded as level III and below; 3. Aged >= 60 years; 4. Body mass index>18kg/m^2, <30kg/m^2; 5. No history of long-term use of NSAIDS, opioids and other analgesic drugs.

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function; 2. Allergy to local anesthetics; 3. Infection at the puncture site cannot implement nerve block; 4. Patients with acute coronary syndrome, heart failure, severe arrhythmia, I, II respiratory failure, diabetic peripheral neuropathy, etc.; 5. Those who cannot understand and complete the pain visual analog scale; 6. Other factors that will affect the results of this experiment.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;	—

Secondary

Measure	Time frame
basic vital signs;	—

Countries

China

Contacts

Public ContactLai Guangyi

Chengdu First People's Hospital

263743189@qq.com+86 13880297922

Outcome results